News > All

Please find below news from the United Kingdom (Great Britain) and the Republic of Ireland as well as about organisations from these countries.

Total search results: 4213 | Ordered by Date (descending)
1 2 3 ... 41 42 43  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
AstraZeneca plc. (8/21/19). "Press Release: Update on the Phase III NEPTUNE Trial of Imfinzi plus Tremelimumab in Stage IV Non-small Cell Lung Cancer". 2019-08-21
Rexgenero. (8/21/19). "Press Release: Atelerix Consortium Awarded £267,000 Innovate UK Grant for Collaboration with the Cell and Gene Therapy Catapult and Rexgenero on Cell Therapy Stabilisation Technologies". London. 2019-08-21
Medicines and Healthcare Products Regulatory Agency (MHRA). (8/20/19). "Press Release: Dr June Raine to Become Interim Chief Executive Officer". 2019-08-20
Nabriva Therapeutics plc. (8/19/19). "Press Release: Nabriva Therapeutics Receives U.S. FDA Approval of Xenleta (lefamulin) to Treat Community-Acquired Bacteria Pneumonia (CABP)". Dublin. 2019-08-19
Juvenescence Ltd.. (8/19/19). "Press Release: Juvenescence Closes $100 Million Series B Round, Plans Follow On and Incremental Investments in Longevity Drug Development". Tortola, British Virgin Islands. 2019-08-19
Nabriva Therapeutics plc. (8/16/19). "Press Release: Nabriva Therapeutics Provides Update on the Planned Resubmission of the New Drug Application for Intravenous Contepo (fosfomycin) for Injection". Dublin. 2019-08-16
Synpromics Ltd.. (8/13/19). "Press Release: AskBio Acquires Synpromics Ltd. and Expands its Gene Therapy Technology Portfolio". Research Triangle Park, NC. 2019-08-13
University College London (UCL). (8/13/19). "Press Release: Biotech Startup Secures £6.5m for Dementia Research". 2019-08-13
GlaxoSmithKline plc. (8/12/19). "Press Release: GSK Announces Leadership Changes in the US". Philadeliphia, PA. 2019-08-12
Circassia Pharmaceuticals plc. (8/12/19). "Press Release: Circassia Appoints Industry Veteran Jonathan Emms as Chief Operating Officer". Oxford. 2019-08-12
Genomics Medicine Ireland Ltd.. (8/12/19). "Press Release: Genomics Medicine Ireland Announces Strategic Advisory Board". 2019-08-12
Jazz Pharmaceuticals plc. (8/12/19). "Press Release: Jazz Pharmaceuticals Announces Acquisition of Cavion, Inc.". Dublin. 2019-08-12
Start Codon Ltd.. (8/9/19). "Press Release: Start Codon Partners with Clustermarket and Science Entrepreneur Club to Support Life Science and Healthcare Start-ups". Cambridge. 2019-08-09
MeiraGTx Holdings plc. (8/8/19). "Press Release: MeiraGTx Announces Pricing of Public Offering of Ordinary Shares". London & New York, NY. 2019-08-08
Bicycle Therapeutics plc. (8/8/19). "Press Release: Bicycle Therapeutics Reports Second Quarter 2019 Financial Results and Provides Clinical Update". Cambridge & Boston, MA. 2019-08-08
MeiraGTx Holdings plc. (8/7/19). "Press Release: MeiraGTx Announces Proposed Public Offering of Ordinary Shares". London & New York, NY. 2019-08-07
MeiraGTx Holdings plc. (8/7/19). "Press Release: MeiraGTx Reports Second Quarter 2019 Financial Results and Provides Corporate Update". London & New York, NY. 2019-08-07
IMBA – Institute of Molecular Biotechnology GmbH. (8/7/19). "Press Release: a:head bio – Launched to Transform CNS Drug Discovery". 2019-08-07
TopiVert Pharma Ltd.. (8/7/19). "Press Release: TopiVert Announces Top-Line Results from THEIA-1 Phase 2b/3 Clinical Study of TOP1630 as a Treatment for Dry Eye Disease". London. 2019-08-07
Expedeon AG. (8/6/19). "Press Release: Expedeon AG Signs Commercial Agreement with Sona Nanotech". Halifax, Heidelberg & Cambridge. 2019-08-06
BioLineRx Ltd.. (8/6/19). "Press Release: BioLineRx Reports Second Quarter 2019 Financial Results and Provides Corporate Update". Tel Aviv. 2019-08-06
Silence Therapeutics plc. (8/5/19). "Press Release: Silence Therapeutics Appoints Jørgen Wittendorff as Head of Manufacturing". London. 2019-08-05
Allogene Therapeutics, Inc.. (8/5/19). "Press Release: Allogene Therapeutics Appoints Rafael G. Amado, M.D. as Executive Vice President of Research and Development and Chief Medical Officer". South San Francisco, CA. 2019-08-05
Sosei Group Corporation (d/b/a Sosei Heptares). (8/5/19). "Press Release: Sosei Heptares and Takeda Enter into New Strategic Multi-target Research, Development and Commercialization Partnership". Tokyo & London. 2019-08-05
Exscientia Ltd.. (8/5/19). "Press Release: Sanofi Exercises Option on Exscientia-designed Bispecific Small Molecule for Treatment of Immunological Conditions". 2019-08-05
Adaptimmune Therapeutics plc. (8/1/19). "Press Release: Adaptimmune Reports Second Quarter 2019 Financial Results and Business Update". Philadeliphia, PA & Oxfordshire. 2019-08-01
Adaptimmune Therapeutics plc. (8/1/19). "Press Release: New Executive Team Announced at Adaptimmune. Adrian Rawcliffe to Assume CEO role from September 1, 2019". Philadeliphia, PA & Oxfordshire. 2019-08-01
Atlantic Healthcare plc. (7/31/19). "Press Release: Atlantic Healthcare Announces Results from Phase 3 Trial of Alicaforsen Enema for Orphan-Designated Pouchitis". Cambridge. 2019-07-31
Sensyne Health plc. (7/31/19). "Press Release: Sensyne Health Signs Collaboration Agreement with Bayer to Accelerate the Development of New Treatments for Cardiovascular Disease Using Clinical Artificial Intelligence". 2019-07-31
PredictImmune Ltd.. (7/30/19). "Press Release: PredictImmune Closes Series B Funding Round, Raising £10M to Further Accelerate Global Commercial Expansion and Support Expanding Product Pipeline". Cambridge. 2019-07-30
Quanta Dialysis Technologies Ltd.. (7/29/19). "Press Release: Quanta Raises $48 million in Series C Funding Round". Alcester, Warwickshire. 2019-07-29
Adaptimmune Therapeutics plc. (7/25/19). "Press Release: Adaptimmune Starts SPEARHEAD-1 Trial with ADP-A2M4 SPEAR T-cells for patients with Synovial Sarcoma or MRCLS". Philadeliphia, PA & Oxfordshire. 2019-07-25
Open Pharma Research Ltd.. (7/23/19). "Press Release: Lab of the Future Congress, 13-14th November 2019, Cambridge UK". Cambridge. 2019-07-23
Adaptimmune Therapeutics plc. (7/22/19). "Press Release: Adaptimmune Has Initiated a Radiation Sub-Study to Enhance Antitumor Activity Seen With ADP-A2M4 in Collaboration with The MD Anderson Cancer Center". Philadeliphia, PA & Oxfordshire. 2019-07-22
Medicxi Ventures. (7/19/19). "Press Release: Medicxi Closes a New €400m Fund (Medicxi III) to Power the Next Wave of Biopharma Entrepreneurs and Drug Hunters". London, Geneva & Jersey. 2019-07-19
Silence Therapeutics plc. (7/18/19). "Press Release: Mallinckrodt to Make an Equity Investment in Silence Therapeutics as Part of a Collaboration". London & Staines-upon-Thames. 2019-07-18
Boehringer Ingelheim. (7/18/19). "Press Release: INMARK Results Suggest Prompt Treatment of IPF with Antifibrotics to Slow Disease Progression". Ingelheim. 2019-07-18
Adaptimmune Therapeutics plc. (7/18/19). "Press Release: Adaptimmune Starts the SURPASS Clinical Trial with Its First Next-Generation SPEAR T-cells Targeting MAGE-A4 to Enhance Antitumor Responses". Philadeliphia, PA & Oxfordshire. 2019-07-18
Silence Therapeutics plc. (7/18/19). "Press Release: Silence Therapeutics and Mallinckrodt Announce Collaboration to Develop and Commercialize RNAi Therapeutics for Complement-mediated Diseases". London & Staines-upon-Thames. 2019-07-18
Arcis Biotechnology Ltd.. (7/16/19). "Press Release: Arcis Biotechnology and Mirnax Biosens Sign Exclusive License Agreement for Arcis Sample Prep Technology". Daresbury & Madrid. 2019-07-16
Sosei Group Corporation (d/b/a Sosei Heptares). (7/16/19). "Press Release: Sosei Heptares Enters into Multi-target Research Collaboration and License Agreement with Genentech". Tokyo & London. 2019-07-16
Recursion Pharmaceuticals, Inc.. (7/15/19). "Press Release: Recursion Pharmaceuticals Secures $121 Million in Series C Financing". Salt Lake City, UT. 2019-07-15
Healx Ltd.. (7/11/19). "Press Release: Dr Neil Thompson Appointed CSO of Healx to Spearhead Drug Discovery Expansion". 2019-07-11
Start Codon Ltd.. (7/10/19). "Press Release: Start Codon Strengthens Senior Team with Key Appointments". Cambridge. 2019-07-10
Consilium Strategic Communications Ltd.. (7/10/19). "Press Release: Consilium Strategic Communications Sponsors Future of Healthcare Investor Forum 2019 at London Stock Exchange". London. 2019-07-10
BioNTech SE. (7/9/19). "Press Release: BioNTech Raises USD 325 Million in an Upsized Series B Financing to Further Advance Individualized Immuno-Oncology Pipeline". Mainz. 2019-07-09
Blue Water Vaccinces, Inc.. (7/9/19). "Press Release: Blue Water Vaccines, Developing Universal Flu Vaccine, Completes $7m Financing Following Successful Preclinical Study". Cincinnati, OH & Oxford. 2019-07-09
PhoreMost Ltd.. (7/8/19). "Press Release: PhoreMost and inStem Enter Structural Biology Alliance". Cambridge. 2019-07-08
Oxford Nanopore Technologies Ltd.. (7/8/19). "Press Release: Scale-up – Oxford Nanopore’s New High-tech Factory Comes Online". Oxford. 2019-07-08
[iito] Business Intelligence. (7/8/19). "Press Release: [iito] Launches Life-Sciences-Benelux.com & Life-Sciences-Scandinavia.com". Bremen. 2019-07-08
Mack Brooks Exhibitions Ltd.. (7/8/19). "Press Release: Trend Barometer Chemspec Europe 2019 Closes with Record in Visitor Numbers and Exhibition Space". 2019-07-08
Evotec SE. (7/8/19). "Press Release: Evotec and Venture Capital Consortium Form Breakpoint Therapeutics GmbH". Hamburg. 2019-07-08
Nosopharm S.A.S.. (7/3/19). "Press Release: Nosopharm and Evotec Enter into Collaboration to Accelerate Development of Novel Antibiotics". Lyon & Hamburg. 2019-07-03
GlaxoSmithKline plc. (7/3/19). "Press Release: ViiV Healthcare Receives EU Marketing Authorisation for Dovato (dolutegravir/lamivudine), a new once-daily, single-pill, two-drug regimen for the treatment of HIV-1 infection". London. 2019-07-03
MorphoSys AG. (7/3/19). "Press Release: MorphoSys' Licensing Partner GSK Initiates Phase 3 Clinical Program With Otilimab (MOR103/GSK3196165) in Rheumatoid Arthritis; MorphoSys Updates its Financial Guidance for 2019". Planegg. 2019-07-03
GlaxoSmithKline plc. (7/3/19). "Press Release: GSK Announces Phase III Start for Its anti GM-CSF Antibody, Otilimab, in Patients with Rheumatoid Arthritis (RA)". London. 2019-07-03
Cancer Research UK. (7/2/19). "Press Release: Cancer Research UK Forms Collaboration with SV Health Investors to Accelerate Development of Cancer Medicines". 2019-07-02
Genedata AG. (7/2/19). "Press Release: Genedata and AB Enzymes Expand Partnership to Digitalize Strain Development". Basel. 2019-07-02
Antibodies.com. (7/2/19). "Press Release: Antibodies.com Raises £400,000 Pre-Seed Round to Help Researchers Discover More For Less". Cambridge. 2019-07-02
ExpreS2ion Biotech Holding AB. (7/1/19). "Press Release: ExpreS2ion Licenses Groundbreaking CRISPR/Cas9 Gene Editing Technology from ERS Genomics". 2019-07-01
[iito] Business Intelligence. (7/1/19). "Press Release: Worldwide First! [iito] Does Away with All Tracking Cookies and Third Party Cookies". Bremen. 2019-07-01
X-Biotix Therapeutics, Inc.. (7/1/19). "Press Release: X-Biotix Therapeutics Joins Antimicrobials Working Group". Washington, DC. 2019-07-01
Ahren Innovation Capital LLP. (7/1/18). "Press Release: Ahren Announces Fund Close". 2019-07-01
Community for Analytical Measurement Science. (6/28/19). "Press Release: Community for Analytical Measurement Science Celebrates Its Launch". London. 2019-06-28
Oncimmune Holdings plc. (6/28/19). "Press Release: Oncimmune Secures Strategic Commercialisation Agreement for EarlyCDT Lung in the US with Biodesix, Inc.". London. 2019-06-28
Adaptimmune Therapeutics plc. (6/27/19). "Press Release: Adrian Rawcliffe to Succeed James Noble as Adaptimmune Chief Executive Officer". Philadeliphia, PA & Oxfordshire. 2019-06-27
Storm Therapeutics Ltd.. (6/27/19). "Press Release: Storm Therapeutics Appoints Dr John Haurum to the Board of Directors". Cambridge. 2019-06-27
Cobra Biologics Ltd.. (6/25/19). "Press Release: Cobra Biologics and Symbiosis Complete £4.8m Viral Vector Supply Chain Collaboration". Keele & Stirling. 2019-06-25
Genedata AG. (6/25/19). "Press Release: Genedata Expands Collaboration with AstraZeneca on Deep Learning for High-Content Image Analysis". Basel. 2019-06-25
Kymab Ltd.. (6/24/19). "Press Release: Kymab and LifeArc Enter Strategic Partnership to Discover New Medicines Using Kymab’s IntelliSelect Technologies". Cambridge. 2019-06-24
GlaxoSmithKline plc. (6/24/19). "Press Release: U.S. Food and Drug Administration Accepts GSK’s Application for Zejula (niraparib) in Late Stage Ovarian Cancer with Priority Review". London. 2019-06-24
Oxford Immunotec Global plc. (6/24/19). "Press Release: Oxford Immunotec Appoints Patrick J. Balthrop, Sr. as Chairman". Oxford & Marlborough, MA. 2019-06-24
Arcus Biosciences, Inc.. (6/24/19). "Press Release: Arcus Biosciences Appoints Global Immuno-Oncology Commercial Leader, Eric Hoefer as Chief Commercial Officer". Hayward, CA. 2019-06-24
Cambridge Innovation Capital plc. (6/21/19). "Press Release: Annual Results for the Year Ended 31 March 2019". 2019-06-21
Selexis S.A.. (6/20/19). "Press Release: Avacta and Selexis Partner to Develop Cell Line for Clinical Manufacturing". Cambridge & Geneva. 2019-06-20
BioCity Group Ltd.. (6/18/19). "Press Release: New Carbon Capture Technology Could Help Industry and Agricultural Sector Decarbonise". 2019-06-18
Illumina, Inc.. (6/17/19). "Press Release: Illumina Wins Infringement Suit Against Ariosa Diagnostics, Inc.". San Diego, CA. 2019-06-17
GlaxoSmithKline plc. (6/13/19). "Press Release: GSK Joins Forces with the University of California to Advance Genomic Research and Improve Drug Discovery". London & San Francisco, CA. 2019-06-13
Medicines Discovery Catapult, The. (6/12/19). "Press Release: Bringing the Benefits of Cutting-edge Mass Spectrometry Technologies to UK SMEs. Medicines Discovery Catapult and Waters Partner". 2019-06-12
Ligand Pharmaceuticals Inc.. (6/12/19). "Press Release: Ligand Subsidiary Vernalis and PhoreMost Limited Announce Drug Discovery Collaboration for Novel Oncology". San Diego, CA & Cambridge. 2019-06-12
Exscientia Ltd.. (6/11/19). "Press Release: Exscientia Expands International Collaborations with Shanghai-headquartered GT Apeiron Therapeutics". Oxford. 2019-06-11
Sphere Fluidics Ltd.. (6/10/19). "Press Release: Sphere Fluidics Closes a $4.8 million USD (£3.7 million) Funding Round". Cambridge. 2019-06-10
Sanofi S.A.. (6/7/19). "Press Release: Paul Hudson to Succeed Olivier Brandicourt as Chief Executive Officer". Paris. 2019-06-07
BioCity Group Ltd.. (6/7/19). "Press Release: New Contract Research Organisation for Platelet Testing". 2019-06-07
Yukin Therapeutics S.A.S.. (6/4/19). "Press Release: Yukin Therapeutics Raises €3.3 million to Develop New Cancer Treatments". Sophia Antipolis. 2019-06-04
LeadXPro AG. (6/3/19). "Press Release: LeadXPro and Astex Enter Strategic Partnership on Membrane Protein Strcuture Research". Cambridge & Villigen. 2019-06-03
University of Warwick. (5/31/19). "Press Release: Disruptive 2D Mass Spectrometry Spin-out Secures Seed Investment". 2019-05-31
Huntsworth plc. (5/30/19). "Press Release: Huntsworth plc Appoints Annabelle Sandeman as Its New Global Head of Commercial Strategy". London. 2019-05-30
[iito] Business Intelligence. (May 2019). "Special Feature: What Does [iito] Stand For? A Powerful Business Database System, based on Property Rights Theory and Institutional Economics = [i]nstitutions [i]nformation [t]echnologies [o]rganisation!". Breme 2019-05-30
BRAIN AG. (5/29/19). "Press Release: BRAIN AG Achieves Significant Growth in the First Half of the 2018/19 Financial Year". Zwingenberg. 2019-05-29
Kintai Therapeutics, Inc.. (5/29/19). "Press Release: Kintai Therapeutics Announces Formation of World-Class Scientific Advisory Board". Cambridge, MA. 2019-05-29
Oxford BioMedica plc. (5/28/19). "Press Release: Oxford BioMedica Announces Strategic Investment by Novo Holdings A/S". Oxford. 2019-05-28
Sciad Communications. (5/24/19). "Press Release: Sold Out Inaugural Bio Integrates Conference a Resounding Success". London. 2019-05-24
Satellite Applications Catapult. (5/23/19). "Press Release: Innovative Partnership to Embed the Power of Satellite Technology in Digitally Enabled Care". 2019-05-23
Storm Therapeutics Ltd.. (5/20/19). "Press Release: Storm Therapeutics Extends Series A to GBP 30M (USD 38.43M) with Wew Investor, Seroba Life Sciences". Cambridge. 2019-05-20
Rinri Therapeutics Ltd.. (5/20/19). "Press Release: Rinri Therapeutics Secures £1.4 Million Seed Funding to Advance Its Novel Regenerative Cell Therapy to Treat Sensorineural Hearing Loss". Sheffield. 2019-05-20
LifeArc. (5/20/19). "Press Release: LifeArc Monetises Keytruda Royalty Interests to Fund further Research and Investment". 2019-05-20
King’s College London. (5/20/19). "Press Release: Quell Therapeutics Ltd Founded for Emerging Area of Cell Therapy". 2019-05-20
Biosynth AG. (5/20/19). "Press Release: Biosynth and Carbosynth Merge to Form a Leading Player in the Global Fine Chemicals Market". Staad & Compton. 2019-05-20
ProBioGen AG. (5/15/19). "Press Release: ProBioGen and Vaccitech Sign License Agreement for ProBioGen’s Technology Platform". Berlin & Oxford. 2019-05-15
1 2 3 ... 41 42 43  next pagenext page



Advertisement

[iito] Business Intelligence – The Elephants Are Coming 560x91px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

» top